iCAD is a global leader in advanced breast cancer detection solutions built on artificial intelligence that empower radiologists to find cancers earlier while improving reading workflow. Our Breast Health Solutions suite delivers powerful detection and workflow solutions for 2D and 3D mammography.
From the Newsroom
November 13, 2018
iCAD Reports Third Quarter 2018 Financial Results
November 9, 2018
iCAD Announces Retirement of CEO, Ken Ferry
» View all news »
ProFound AI Reader Study Results
Discover a revolutionary, deep-learning, cancer detection solution for digital breast tomosynthesis.
Powered by more than 12,000 patient cases, ProFound AI is proven through a rigorous clinical study to help clinicians find more cancer, decrease false positives, reduce recalls and reading time.
Inform, connect and engage. We invite you to engage with us to participate on the topic of cancer detection solutions, patient stories, clinical expertise.
Southwest Diagnostic Imaging Center Uses Artificial Intelligence to Optimize Breast Tomosynthesis Interpretations
Improving reading time of digital breast tomosynthesis with concurrent computer aided detection.
Supporting cancer detection for 3,500+ healthcare facilities worldwide
Speak to a specialist today at 1.866.280.2239
© 2018, iCAD Inc. All rights reserved. iCAD, the iCAD logo,, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.